Sputnik V shows superior antibody levels against Omicron variant

By NS Healthcare Staff Writer

21 Jan 22

People who received two doses of Sputnik V showed high levels of antibodies against Omicron than those vaccinated…

PharmaceuticalsClinical trials

AstraZeneca’s STRIDE regimen shows positive survival outcomes in liver cancer trial

By NS Healthcare Staff Writer

19 Jan 22

The combination also showed no increase in severe liver toxicity and fewer discontinuations due to treatment-related adverse events…

PharmaceuticalsClinical trials

Pfizer unveils positive results for Prevnar 20, Comirnaty booster coadministration

By NS Healthcare Staff Writer

13 Jan 22

In the Phase 3 study, PREVNAR 20 vaccine triggered similar responses for all 20 serotypes, either with Pfizer-BioNTech…

PharmaceuticalsClinical trials

Medicago, GSK unveil positive results for plant-based Covid-19 vaccine candidate

By NS Healthcare Staff Writer

08 Dec 21

The vaccine showed 71% overall efficacy against all variants of SARS-COV-2, and 75.6% in people who were not…

PharmaceuticalsClinical trials

AstraZeneca, Moderna’s AZD8601 meets primary endpoint in Phase 2 EPICCURE trial

By NS Healthcare Staff Writer

16 Nov 21

AZD8601 is an mRNA therapeutic that encodes for vascular endothelial growth factor-A (VEGF-A), jointly developed by AstraZeneca and…

PharmaceuticalsClinical trials

Covaxin shows 77.8% efficacy against Covid-19: Lancet Study

By NS Healthcare Staff Writer

12 Nov 21

The 77.8% vaccine efficacy was based on 130 confirmed cases, where 24 cases were observed in the vaccine…

PharmaceuticalsClinical trials

Gilead, Merck begin Phase 2 study of investigational HIV treatment regimen

By NS Healthcare Staff Writer

27 Oct 21

The regimen includes Merck’s nucleoside reverse transcriptase translocation inhibitor islatravir and Gilead’s potential capsid inhibitor lenacapavir

PharmaceuticalsClinical trials

Novartis’ cancer drug canakinumab fails in Phase 3 CANOPY-1 trial

By NS Healthcare Staff Writer

26 Oct 21

The Phase 3 CANOPY-1 study did not meet its primary endpoints of OS and PFS in patients with…

PharmaceuticalsClinical trials

Moderna’s Covid-19 vaccine found effective in kids aged six to 11 years: Study

By NS Healthcare Staff Writer

26 Oct 21

In the Phase 2/3 study, two 50μg doses of mRNA-1273 were generally well tolerated and showed superior neutralising…

PharmaceuticalsClinical trials

Biological E seeks DGCI approval to study Corbevax as booster dose

By NS Healthcare Staff Writer

13 Oct 21

Corbevax is an RBD protein sub-unit vaccine currently under Phase 2/3 clinical trials in adults aged 18 years…

PharmaceuticalsClinical trials